fbpx
Medical Innovation Exchange

CRISPR Tx's Innovation Day dragged down by multiple myeloma replacement, lackluster results in kidney cancer

https://www.fiercebiotech.com/biotech/crispr-distances-itself-multiple-myeloma-candidate-sees-stock-fall-amid-innovation-day

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.